Montrusco Bolton Investments Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$76.7M |
| 2 |
CME Group
CME
|
+$76.3M |
| 3 |
Charles Schwab
SCHW
|
+$73.2M |
| 4 |
GE Vernova
GEV
|
+$11.6M |
| 5 |
SK Hynix Inc
SKHY
|
+$9.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$102M |
| 2 |
JPMorgan Chase
JPM
|
+$101M |
| 3 |
NVIDIA
NVDA
|
+$74.8M |
| 4 |
Amazon
AMZN
|
+$68.3M |
| 5 |
Broadcom
AVGO
|
+$63.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.12% |
| 2 | Financials | 12.84% |
| 3 | Communication Services | 9.4% |
| 4 | Healthcare | 9.28% |
| 5 | Consumer Discretionary | 8.37% |
Similar funds
Montrusco Bolton Investments's Q3 2026 Portfolio in Review
As of Q3 2026, Montrusco Bolton Investments held 91 positions worth $5.77B, down 11% from $6.46B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Montrusco Bolton Investments withdrew a net $865M in Q3 2026, closing 6 positions and reducing 60 holdings. Its most notable exit was Blackrock, an estimated $41.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 37% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Montrusco Bolton Investments opened a new position in Vertex Pharmaceuticals worth $78.4M.
- Montrusco Bolton Investments's largest Q3 2026 buy was Vertex Pharmaceuticals: 149,888 shares worth $78.4M.
- Montrusco Bolton Investments added most to GE Vernova in Q3 2026, an estimated $11.6M increase.
- Montrusco Bolton Investments's biggest Q3 2026 reduction was Mastercard, cutting an estimated $102M.
- Montrusco Bolton Investments fully exited Blackrock in Q3 2026, selling an estimated $41.7M.
- Montrusco Bolton Investments's ten largest holdings make up 49% of its $5.77B portfolio in Q3 2026.
- Montrusco Bolton Investments opened 11 new positions and closed 6 in Q3 2026.
- Montrusco Bolton Investments's portfolio value fell 11% quarter-over-quarter to $5.77B.
Based on Montrusco Bolton Investments's 13F filing for Q3 2026, filed 13 Oct 2026.